{
    "N/R/U": null,
    "Applicant": "GlaxoSmithKline Biologicals",
    "BLA Number": "125775",
    "Proprietary Name": "Arexvy",
    "Proper Name": "Respiratory Syncytial Virus Vaccine, Adjuvanted",
    "BLA Type": "351(a)",
    "Strength": "120UG/.5ML",
    "Dosage Form": "For Injection",
    "Route of Administration": "Intramuscular",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "May 03, 2023",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "1617",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": "May 03, 2023",
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": "May 03, 2035",
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "Respiratory Syncytial Virus Vaccine, Adjuvanted",
            "drugbank_id": "https://go.drugbank.com/drugs/DB17762"
        }
    ]
}